{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T15:51:58Z","timestamp":1786981918245,"version":"build-2736575974"},"reference-count":89,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2026,1,14]],"date-time":"2026-01-14T00:00:00Z","timestamp":1768348800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,1,14]],"date-time":"2026-01-14T00:00:00Z","timestamp":1768348800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/100014437","name":"Wenner-Gren Stiftelserna","doi-asserted-by":"publisher","award":["WGF2022-0044"],"award-info":[{"award-number":["WGF2022-0044"]}],"id":[{"id":"10.13039\/100014437","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004359","name":"Vetenskapsr\u00e5det","doi-asserted-by":"publisher","award":["2024-05621"],"award-info":[{"award-number":["2024-05621"]}],"id":[{"id":"10.13039\/501100004359","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100006353","name":"Kjell och M\u00e4rta Beijers Stiftelse","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100006353","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Bull Math Biol"],"published-print":{"date-parts":[[2026,2]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>Mathematical modelling is a widely used approach to understand and interpret clinical trial data. This modelling typically involves fitting mechanistic mathematical models to data from individual trial participants. Despite the widespread adoption of this individual-based fitting, it is becoming increasingly common to take a hierarchical approach to parameter estimation, where modellers characterize the population parameter distributions, rather than considering each individual independently. This hierarchical parameter estimation is standard in pharmacometric modelling. However, many of the existing techniques for parameter identifiability do not immediately translate from the individual-based fitting to the hierarchical setting. In this work, we propose a nonparametric approach to study practical identifiability within a hierarchical parameter estimation framework. We focus on the commonly used nonlinear mixed effects framework and investigate two well-studied examples from the pharmacometrics and viral dynamics literature to illustrate the potential utility of our approach.<\/jats:p>","DOI":"10.1007\/s11538-025-01583-2","type":"journal-article","created":{"date-parts":[[2026,1,14]],"date-time":"2026-01-14T03:57:24Z","timestamp":1768363044000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["A Nonparametric Approach to Practical Identifiability of Nonlinear Mixed Effects Models"],"prefix":"10.1007","volume":"88","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-0757-0017","authenticated-orcid":false,"given":"Tyler","family":"Cassidy","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stuart T.","family":"Johnston","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"Plank","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Imke","family":"Botha","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jennifer A.","family":"Flegg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ryan J.","family":"Murphy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sara","family":"Hamis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,1,14]]},"reference":[{"key":"1583_CR1","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1128\/JVI.02098-17","volume":"92","author":"TR Aunins","year":"2018","unstructured":"Aunins TR, Marsh KA, Subramanya G, Uprichard SL, Perelson AS, Chatterjee A (2018) Intracellular hepatitis C virus modeling predicts infection dynamics and viral protein mechanisms. J Virol 92:1\u201321","journal-title":"J Virol"},{"key":"1583_CR2","doi-asserted-by":"publisher","first-page":"52","DOI":"10.1016\/j.cmpb.2007.07.002","volume":"88","author":"G Bellu","year":"2007","unstructured":"Bellu G, Saccomani MP, Audoly S, D\u2019Angi\u00f2 L (2007) DAISY: a new software tool to test global identifiability of biological and physiological systems. Comput Methods Programs Biomed 88:52\u201361","journal-title":"Comput Methods Programs Biomed"},{"key":"1583_CR3","doi-asserted-by":"publisher","first-page":"268","DOI":"10.1002\/psp4.13270","volume":"14","author":"N Braniff","year":"2025","unstructured":"Braniff N, Joshi T, Cassidy T, Trogdon M, Kumar R, Poels K, Allen R, Musante CJ, Shtylla B (2025) An integrated quantitative systems pharmacology virtual population approach for calibration with oncology efficacy endpoints. CPT Pharmacometrics Syst Pharmacol 14:268\u2013278","journal-title":"CPT Pharmacometrics Syst Pharmacol"},{"key":"1583_CR4","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pcbi.1013202","volume":"21","author":"AP Browning","year":"2025","unstructured":"Browning AP, Crossley RM, Villa C, Maini PK, Jenner AL, Cassidy T, Hamis S (2025) Identifiability of phenotypic adaptation from low-cell-count experiments and a stochastic model. PLoS Comput Biol 21:e1013202","journal-title":"PLoS Comput Biol"},{"key":"1583_CR5","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1007\/s10928-017-9560-y","volume":"45","author":"D C\u00e2mara De Souza","year":"2018","unstructured":"C\u00e2mara De Souza D, Craig M, Cassidy T, Li J, Nekka F, B\u00e9lair J, Humphries AR (2018) Transit and lifespan in neutrophil production: implications for drug intervention. J Pharmacokinet Pharmacodyn 45:59\u201377","journal-title":"J Pharmacokinet Pharmacodyn"},{"key":"1583_CR6","doi-asserted-by":"publisher","first-page":"2348","DOI":"10.1111\/cts.13099","volume":"14","author":"Y Cao","year":"2021","unstructured":"Cao Y, Gao W, Caro L, Stone JA (2021) Immune-viral dynamics modeling for SARS-CoV-2 drug development. Clin Transl Sci 14:2348\u20132359","journal-title":"Clin Transl Sci"},{"key":"1583_CR7","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3389\/fimmu.2021.710012","volume":"12","author":"EF Cardozo-Ojeda","year":"2021","unstructured":"Cardozo-Ojeda EF, Perelson AS (2021) Modeling HIV-1 within-host dynamics after passive infusion of the broadly neutralizing antibody VRC01. Front Immunol 12:1\u201320","journal-title":"Front Immunol"},{"key":"1583_CR8","doi-asserted-by":"publisher","first-page":"1","DOI":"10.18637\/jss.v076.i01","volume":"76","author":"B Carpenter","year":"2017","unstructured":"Carpenter B, Gelman A, Hoffman MD, Lee D, Goodrich B, Betancourt M, Brubaker M, Guo J, Li P, Riddell A (2017) Stan: a probabilistic programming language. J Stat Softw 76:1\u201332","journal-title":"J Stat Softw"},{"key":"1583_CR9","doi-asserted-by":"publisher","first-page":"90","DOI":"10.1007\/s11538-023-01200-0","volume":"85","author":"T Cassidy","year":"2023","unstructured":"Cassidy T (2023) A continuation technique for maximum likelihood estimators in biological models. Bull Math Biol 85:90","journal-title":"Bull Math Biol"},{"key":"1583_CR10","doi-asserted-by":"publisher","first-page":"104","DOI":"10.1007\/s11538-020-00777-0","volume":"82","author":"T Cassidy","year":"2020","unstructured":"Cassidy T, Humphries AR, Craig M, Mackey MC (2020) Characterizing chemotherapy-induced neutropenia and monocytopenia through mathematical modelling. Bull Math Biol 82:104","journal-title":"Bull Math Biol"},{"key":"1583_CR11","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pcbi.1011518","volume":"20","author":"T Cassidy","year":"2024","unstructured":"Cassidy T, Stephenson KE, Barouch DH, Perelson AS (2024) Modeling resistance to the broadly neutralizing antibody PGT121 in people living with HIV-1. PLoS Comput Biol 20:e1011518","journal-title":"PLoS Comput Biol"},{"key":"1583_CR12","doi-asserted-by":"publisher","first-page":"19851","DOI":"10.1073\/pnas.0810032105","volume":"105","author":"M Catalfamo","year":"2008","unstructured":"Catalfamo M, Di Mascio M, Hu Z, Srinivasula S, Thaker V, Adelsberger J, Rupert A, Baseler M, Tagaya Y, Roby G, Rehm C, Follmann D, Lane HC (2008) HIV infection-associated immune activation occurs by two distinct pathways that differentially affect CD4 and CD8 T cells. Proc Natl Acad Sci USA 105:19851\u201319856","journal-title":"Proc Natl Acad Sci USA"},{"key":"1583_CR13","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1007\/s11538-024-01266-4","volume":"86","author":"M-V Ciocanel","year":"2024","unstructured":"Ciocanel M-V, Ding L, Mastromatteo L, Reichheld S, Cabral S, Mowry K, Sandstede B (2024) Parameter identifiability in PDE models of fluorescence recovery after photobleaching. Bull Math Biol 86:36","journal-title":"Bull Math Biol"},{"key":"1583_CR14","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pcbi.1011282","volume":"19","author":"Q Clairon","year":"2023","unstructured":"Clairon Q, Prague M, Planas D, Bruel T, Hocqueloux L, Prazuck T, Schwartz O, Thi\u00e9baut R, Guedj J (2023) Modeling the kinetics of the neutralizing antibody response against SARS-CoV-2 variants after several administrations of Bnt162b2. PLoS Comput Biol 19:e1011282","journal-title":"PLoS Comput Biol"},{"key":"1583_CR15","doi-asserted-by":"publisher","first-page":"99","DOI":"10.2165\/00003088-199936020-00002","volume":"36","author":"SJ Clarke","year":"1999","unstructured":"Clarke SJ, Rivory LP (1999) Clinical pharmacokinetics of docetaxel. Clin Pharmacokinet 36:99\u2013114","journal-title":"Clin Pharmacokinet"},{"key":"1583_CR16","doi-asserted-by":"publisher","first-page":"5467","DOI":"10.1073\/pnas.1419162112","volume":"112","author":"JM Conway","year":"2015","unstructured":"Conway JM, Perelson AS (2015) Post-treatment control of HIV infection. Proc Natl Acad Sci USA 112:5467\u20135472","journal-title":"Proc Natl Acad Sci USA"},{"key":"1583_CR17","doi-asserted-by":"publisher","first-page":"600","DOI":"10.1002\/cpt.3718","volume":"118","author":"J Cort\u00e9s-R\u00edos","year":"2025","unstructured":"Cort\u00e9s-R\u00edos J, Ren T, Hanan N, Sher A, Nader A, Magee M, Jusko WJ, Desikan R (2025) Hepatitis B in silico trials capture functional cure, indicate mechanistic pathways, and suggest prognostic biomarker signatures. Clin Pharmacol Ther 118:600\u2013612","journal-title":"Clin Pharmacol Ther"},{"key":"1583_CR18","doi-asserted-by":"publisher","first-page":"293","DOI":"10.1002\/psp4.12191","volume":"6","author":"M Craig","year":"2017","unstructured":"Craig M (2017) Towards quantitative systems pharmacology models of chemotherapy-induced neutropenia. CPT Pharmacometrics Syst Pharmacol 6:293\u2013304","journal-title":"CPT Pharmacometrics Syst Pharmacol"},{"key":"1583_CR19","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3389\/fsysb.2023.1174647","volume":"3","author":"M Craig","year":"2023","unstructured":"Craig M, Gevertz JL, Kareva I, Wilkie KP (2023) A practical guide for the generation of model-based virtual clinical trials. Front Syst Biol 3:1\u201314","journal-title":"Front Syst Biol"},{"key":"1583_CR20","doi-asserted-by":"publisher","first-page":"2304","DOI":"10.1007\/s11538-016-0179-8","volume":"78","author":"M Craig","year":"2016","unstructured":"Craig M, Humphries AR, Mackey MC (2016) A mathematical model of granulopoiesis incorporating the negative feedback dynamics and kinetics of G-CSF\/neutrophil binding and internalization. Bull Math Biol 78:2304\u20132357","journal-title":"Bull Math Biol"},{"key":"1583_CR21","doi-asserted-by":"publisher","first-page":"94","DOI":"10.1214\/aos\/1018031103","volume":"27","author":"B Delyon","year":"1999","unstructured":"Delyon B, Lavielle M, Moulines E (1999) Convergence of a stochastic approximation version of the EM algorithm. Ann Stat 27:94\u2013128","journal-title":"Ann Stat"},{"key":"1583_CR22","doi-asserted-by":"publisher","first-page":"194","DOI":"10.1137\/22M1469067","volume":"7","author":"R Dong","year":"2023","unstructured":"Dong R, Goodbrake C, Harrington HA, Pogudin G (2023) Differential elimination for dynamical models via projections with applications to structural identifiability. SIAM J Appl Algebr Geom 7:194\u2013235","journal-title":"SIAM J Appl Algebr Geom"},{"key":"1583_CR23","doi-asserted-by":"publisher","first-page":"478","DOI":"10.1186\/s12859-021-04373-4","volume":"22","author":"R Duchesne","year":"2021","unstructured":"Duchesne R, Guillemin A, Gandrillon O, Crauste F (2021) Practical identifiability in the frame of nonlinear mixed effects models: the example of the in vitro erythropoiesis. BMC Bioinformatics 22:478","journal-title":"BMC Bioinformatics"},{"key":"1583_CR24","doi-asserted-by":"publisher","first-page":"390","DOI":"10.1002\/cpt.2798","volume":"113","author":"S El Messaoudi","year":"2023","unstructured":"El Messaoudi S, Lemenuel-Diot A, Gon\u00e7alves A, Guedj J (2023) A semi-mechanistic model to characterize the long-term dynamics of hepatitis B virus markers during treatment with lamivudine and pegylated interferon clin. Pharmacol Ther 113:390\u2013400","journal-title":"Pharmacol Ther"},{"key":"1583_CR25","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1007\/s10928-018-9569-x","volume":"45","author":"ND Evans","year":"2018","unstructured":"Evans ND, Cheung SYA, Yates JWT (2018) Structural identifiability for mathematical pharmacology: models of myelosuppression. J Pharmacokinet Pharmacodyn 45:79\u201390","journal-title":"J Pharmacokinet Pharmacodyn"},{"key":"1583_CR26","doi-asserted-by":"publisher","first-page":"4713","DOI":"10.1200\/JCO.2002.02.140","volume":"20","author":"LE Friberg","year":"2002","unstructured":"Friberg LE, Henningsson A, Maas H, Nguyen L, Karlsson MO (2002) Model of chemotherapy-induced myelosuppression with parameter consistency across drugs. J Clin Oncol 20:4713\u20134721","journal-title":"J Clin Oncol"},{"key":"1583_CR27","doi-asserted-by":"publisher","first-page":"1","DOI":"10.15252\/msb.202210988","volume":"19","author":"F Fr\u00f6hlich","year":"2023","unstructured":"Fr\u00f6hlich F, Gerosa L, Muhlich J, Sorger PK (2023) Mechanistic model of<scp>MAPK<\/scp> signaling reveals how allostery and rewiring contribute to drug resistance. Mol Syst Biol 19:1\u201326","journal-title":"Mol Syst Biol"},{"key":"1583_CR28","first-page":"1","volume":"24","author":"H Gao","year":"2023","unstructured":"Gao H, Shao X (2023) Two sample testing in high dimension via maximum mean discrepancy. J Mach Learn Res 24:1\u201333","journal-title":"J Mach Learn Res"},{"key":"1583_CR29","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pcbi.1002971","volume":"9","author":"JB Gilmore","year":"2013","unstructured":"Gilmore JB, Kelleher AD, Cooper DA, Murray JM (2013) Explaining the determinants of first phase HIV decay dynamics through the effects of stage-dependent drug action. PLoS Comput Biol 9:e1002971","journal-title":"PLoS Comput Biol"},{"key":"1583_CR30","doi-asserted-by":"publisher","first-page":"383","DOI":"10.1111\/jvh.13425","volume":"28","author":"A Gon\u00e7alves","year":"2021","unstructured":"Gon\u00e7alves A, Lemenuel-Diot A, Cosson V, Jin Y, Feng S, Bo Q, Guedj J (2021) What drives the dynamics of HBV RNA during treatment? J Viral Hepat 28:383\u2013392","journal-title":"J Viral Hepat"},{"key":"1583_CR31","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1016\/j.coisb.2019.10.003","volume":"18","author":"A Goyal","year":"2019","unstructured":"Goyal A, Liao LE, Perelson AS (2019) Within-host mathematical models of hepatitis B virus infection: past, present, and future. Curr Opin Syst Biol 18:27\u201335","journal-title":"Curr Opin Syst Biol"},{"key":"1583_CR32","first-page":"723","volume":"13","author":"A Gretton","year":"2012","unstructured":"Gretton A, Borgwardt KM, Rasch MJ, Sch\u00f6lkopf B, Smola A (2012) A kernel two-sample test. J Mach Learn Res 13:723\u2013773","journal-title":"J Mach Learn Res"},{"key":"1583_CR33","doi-asserted-by":"publisher","first-page":"1801","DOI":"10.1002\/hep.24272","volume":"53","author":"J Guedj","year":"2011","unstructured":"Guedj J, Perelson AS (2011) Second-phase hepatitis C virus RNA decline during telaprevir-based therapy increases with drug effectiveness: implications for treatment duration. Hepatology 53:1801\u20131808","journal-title":"Hepatology"},{"issue":"1","key":"1583_CR34","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1111\/imr.12698","volume":"285","author":"AL Hill","year":"2018","unstructured":"Hill AL, Rosenbloom DIS, Nowak MA, Siliciano RF (2018) Insight into treatment of HIV infection from viral dynamics models. Immunol Rev 285(1):9\u201325","journal-title":"Immunol Rev"},{"key":"1583_CR35","doi-asserted-by":"publisher","first-page":"1528","DOI":"10.1093\/cid\/ciab587","volume":"73","author":"SD Ismail","year":"2021","unstructured":"Ismail SD, Riou C, Joseph SB, Archin NM, Margolis DM, Perelson AS, Cassidy T, Abrahams M-R, Moeser M, Council OD, McKinnon LR, Osman F, Karim QA, Abdool Karim SS, Swanstrom R, Williamson C, Garrett NJ, Burgers WA (2021) Immunological correlates of the HIV-1 replication-competent reservoir size. Clin Infect Dis 73:1528\u20131531","journal-title":"Clin Infect Dis"},{"key":"1583_CR36","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pcbi.1012322","volume":"21","author":"SA Iyaniwura","year":"2025","unstructured":"Iyaniwura SA, Cassidy T, Ribeiro RM, Perelson AS (2025) A multiscale model of the action of a capsid assembly modulator for the treatment of chronic hepatitis B. PLoS Comput Biol 21:e1012322","journal-title":"PLoS Comput Biol"},{"key":"1583_CR37","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.mbs.2017.10.009","volume":"295","author":"DL Janz\u00e9n","year":"2018","unstructured":"Janz\u00e9n DL, Jirstrand M, Chappell MJ, Evans ND (2018) Extending existing structural identifiability analysis methods to mixed-effects models. Math Biosci 295:1\u201310","journal-title":"Math Biosci"},{"key":"1583_CR38","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3389\/fphys.2016.00590","volume":"7","author":"DLI Janz\u00e9n","year":"2016","unstructured":"Janz\u00e9n DLI, Bergenholm L, Jirstrand M, Parkinson J, Yates J, Evans ND, Chappell MJ (2016) Parameter identifiability of fundamental pharmacodynamic models. Front Physiol 7:1\u201312","journal-title":"Front Physiol"},{"key":"1583_CR39","doi-asserted-by":"publisher","DOI":"10.1371\/journal.ppat.1009753","volume":"17","author":"AL Jenner","year":"2021","unstructured":"Jenner AL, Aogo RA, Alfonso S, Crowe V, Deng X, Smith AP, Morel PA, Davis CL, Smith AM, Craig M (2021) COVID-19 virtual patient cohort suggests immune mechanisms driving disease outcomes. PLoS Pathog 17:e1009753","journal-title":"PLoS Pathog"},{"key":"1583_CR40","doi-asserted-by":"publisher","DOI":"10.1136\/jitc-2020-001387","volume":"9","author":"AL Jenner","year":"2021","unstructured":"Jenner AL, Cassidy T, Belaid K, Bourgeois-Daigneault M-C, Craig M (2021) In silico trials predict that combination strategies for enhancing vesicular stomatitis oncolytic virus are determined by tumor aggressivity. J Immunother Cancer 9:e001387","journal-title":"J Immunother Cancer"},{"key":"1583_CR41","doi-asserted-by":"publisher","first-page":"640","DOI":"10.1038\/s41564-022-01105-z","volume":"7","author":"R Ke","year":"2022","unstructured":"Ke R, Martinez PP, Smith RL, Gibson LL, Mirza A, Conte M, Gallagher N, Luo CH, Jarrett J, Zhou R, Conte A, Liu T, Farjo M, Walden KKO, Rendon G, Fields CJ, Wang L, Fredrickson R, Edmonson DC, Baughman ME, Chiu KK, Choi H, Scardina KR, Bradley S, Gloss SL, Reinhart C, Yedetore J, Quicksall J, Owens AN, Broach J, Barton B, Lazar P, Heetderks WJ, Robinson ML, Mostafa HH, Manabe YC, Pekosz A, McManus DD, Brooke CB (2022) Daily longitudinal sampling of SARS-CoV-2 infection reveals substantial heterogeneity in infectiousness. Nat Microbiol 7:640\u2013652","journal-title":"Nat Microbiol"},{"key":"1583_CR42","doi-asserted-by":"publisher","first-page":"923","DOI":"10.1111\/j.1742-4658.2008.06843.x","volume":"276","author":"C Kreutz","year":"2009","unstructured":"Kreutz C, Timmer J (2009) Systems biology: experimental design. FEBS J 276:923\u2013942","journal-title":"FEBS J"},{"key":"1583_CR43","doi-asserted-by":"publisher","first-page":"1020","DOI":"10.1016\/j.csda.2004.07.002","volume":"49","author":"E Kuhn","year":"2005","unstructured":"Kuhn E, Lavielle M (2005) Maximum likelihood estimation in nonlinear mixed effects models. Comput Stat Data Anal 49:1020\u20131038","journal-title":"Comput Stat Data Anal"},{"key":"1583_CR44","doi-asserted-by":"publisher","DOI":"10.1201\/b17203","volume-title":"Mixed effects models for the population approach","author":"M Lavielle","year":"2014","unstructured":"Lavielle M (2014) Mixed effects models for the population approach. Chapman and Hall\/CRC, London"},{"key":"1583_CR45","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1007\/s10928-015-9459-4","volume":"43","author":"M Lavielle","year":"2016","unstructured":"Lavielle M, Aarons L (2016) What do we mean by identifiability in mixed effects models? J Pharmacokinet Pharmacodyn 43:111\u2013122","journal-title":"J Pharmacokinet Pharmacodyn"},{"key":"1583_CR46","doi-asserted-by":"publisher","first-page":"1104","DOI":"10.1126\/science.adf7966","volume":"383","author":"S-Y Lim","year":"2024","unstructured":"Lim S-Y, Lee J, Osuna CE, Vikhe P, Schalk DR, Chen E, Fray E, Kumar M, Schultz-Darken N, Rakasz E, Capuano S, Ladd RA, Gil HM, Evans DT, Jeng EK, Seaman M, Martin M, Van Dorp C, Perelson AS, Wong HC, Siliciano JD, Siliciano R, Safrit JT, Nixon DF, Soon-Shiong P, Nussenzweig M, Whitney JB (2024) Induction of durable remission by dual immunotherapy in SHIV-infected ART-suppressed macaques. Science 383:1104\u20131111","journal-title":"Science"},{"key":"1583_CR47","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pcbi.1010651","volume":"18","author":"NJ Linden","year":"2022","unstructured":"Linden NJ, Kramer B, Rangamani P (2022) Bayesian parameter estimation for dynamical models in systems biology. PLoS Comput Biol 18:e1010651","journal-title":"PLoS Comput Biol"},{"key":"1583_CR48","doi-asserted-by":"publisher","DOI":"10.1103\/PhysRevE.110.044405","volume":"110","author":"Y Liu","year":"2024","unstructured":"Liu Y, Warne DJ, Simpson MJ (2024) Likelihood-based inference, identifiability, and prediction using count data from lattice-based random walk models. Phys Rev E 110:044405","journal-title":"Phys Rev E"},{"key":"1583_CR49","doi-asserted-by":"crossref","unstructured":"Luo R, Piovoso MJ, Martinez-Picado J, Zurakowski R (2012) HIV model parameter estimates from interruption trial data including drug efficacy and reservoir dynamics. PLOS One 7:7e40198","DOI":"10.1371\/journal.pone.0040198"},{"key":"1583_CR50","doi-asserted-by":"publisher","DOI":"10.1063\/5.0006517","volume":"30","author":"MC Mackey","year":"2020","unstructured":"Mackey MC (2020) Periodic hematological disorders: quintessential examples of dynamical diseases. Chaos An Interdiscip J Nonlinear Sci 30:063123","journal-title":"Chaos An Interdiscip J Nonlinear Sci"},{"key":"1583_CR51","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pcbi.1012129","volume":"20","author":"E Mainou","year":"2024","unstructured":"Mainou E, Ribeiro RM, Conway JM (2024) Modeling dynamics of acute HIV infection incorporating density-dependent cell death and multiplicity of infection. PLoS Comput Biol 20:e1012129","journal-title":"PLoS Comput Biol"},{"key":"1583_CR52","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1371\/journal.pone.0162366","volume":"11","author":"T Maiwald","year":"2016","unstructured":"Maiwald T, Hass H, Steiert B, Vanlier J, Engesser R, Raue A, Kipkeew F, Bock HH, Kaschek D, Kreutz C, Timmer J (2016) Driving the model to its limit: profile likelihood based model reduction. PLoS ONE 11:1\u201318","journal-title":"PLoS ONE"},{"key":"1583_CR53","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pcbi.1010721","volume":"19","author":"A Marc","year":"2023","unstructured":"Marc A, Marlin R, Donati F, Prague M, Kerioui M, H\u00e9rate C, Alexandre M, Dereuddre-bosquet N, Bertrand J, Contreras V, Behillil S, Maisonnasse P, Van Der Werf S, Le Grand R, Guedj J (2023) Impact of variants of concern on SARS-CoV-2 viral dynamics in non-human primates. PLoS Comput Biol 19:e1010721","journal-title":"PLoS Comput Biol"},{"key":"1583_CR54","doi-asserted-by":"publisher","first-page":"479","DOI":"10.1038\/s41586-018-0531-2","volume":"561","author":"P Mendoza","year":"2018","unstructured":"Mendoza P, Gruell H, Nogueira L, Pai JA, Butler AL, Millard K, Lehmann C, Su\u00e1rez I, Oliveira TY, Lorenzi JCC, Cohen YZ, Wyen C, K\u00fcmmerle T, Karagounis T, Lu C-L, Handl L, Unson-O\u2019Brien C, Patel R, Ruping C, Schlotz M, Witmer-Pack M, Shimeliovich I, Kremer G, Thomas E, Seaton KE, Horowitz J, West AP, Bjorkman PJ, Tomaras GD, Gulick RM, Pfeifer N, F\u00e4tkenheuer G, Seaman MS, Klein F, Caskey M, Nussenzweig MC (2018) Combination therapy with anti-HIV-1 antibodies maintains viral suppression. Nature 561:479\u2013484","journal-title":"Nature"},{"key":"1583_CR55","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1137\/090757009","volume":"53","author":"H Miao","year":"2011","unstructured":"Miao H, Xia X, Perelson AS, Wu H (2011) On identifiability of nonlinear ODE models and applications in viral dynamics. SIAM Rev 53:3\u201339","journal-title":"SIAM Rev"},{"key":"1583_CR56","doi-asserted-by":"crossref","unstructured":"Mohri H, Perelson AS, Tung K, Ribeiro RM, Ramratnam B, Markowitz M, Kost R, Hurley WL, Cesar D, Hellerstein MK, Ho DD (2001) Increased turnover of T lymphocytes in HIV-1 infection and its reduction by antiretroviral therapy. J Exp Med 194:1277\u20131288","DOI":"10.1084\/jem.194.9.1277"},{"key":"1583_CR57","doi-asserted-by":"publisher","DOI":"10.1002\/psp4.70033","volume-title":"Virtual clinical trial reveals significant clinical potential of targeting tumor-associated macrophages and microglia to treat glioblastoma","author":"B Mongeon","year":"2025","unstructured":"Mongeon B, Craig M (2025) Virtual clinical trial reveals significant clinical potential of targeting tumor-associated macrophages and microglia to treat glioblastoma. CPT Pharmacometrics Syst, Pharmacol"},{"issue":"210","key":"1583_CR58","doi-asserted-by":"publisher","first-page":"20230402","DOI":"10.1098\/rsif.2023.0402","volume":"21","author":"RJ Murphy","year":"2024","unstructured":"Murphy RJ, Maclaren OJ, Simpson MJ (2024) Implementing measurement error models with mechanistic mathematical models in a likelihood-based framework for estimation, identifiability analysis and prediction in the life sciences. J R Soc Interface 21(210):20230402","journal-title":"J R Soc Interface"},{"key":"1583_CR59","doi-asserted-by":"publisher","first-page":"4531","DOI":"10.1128\/JCM.41.10.4531-4536.2003","volume":"41","author":"S Palmer","year":"2003","unstructured":"Palmer S, Wiegand AP, Maldarelli F, Bazmi H, Mican JM, Polis M, Dewar RL, Planta A, Liu S, Metcalf JA, Mellors JW, Coffin JM (2003) New real-time reverse transcriptase-initiated PCR assay with single-copy sensitivity for human immunodeficiency virus type 1 RNA in plasma. J Clin Microbiol 41:4531\u20134536","journal-title":"J Clin Microbiol"},{"key":"1583_CR60","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3389\/fpsyg.2019.01089","volume":"10","author":"M Pastore","year":"2019","unstructured":"Pastore M, Calcagn\u00ec A (2019) Measuring distribution similarities between samples: a distribution-free overlapping index. Front Psychol 10:1\u20138","journal-title":"Front Psychol"},{"key":"1583_CR61","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1038\/nri700","volume":"2","author":"AS Perelson","year":"2002","unstructured":"Perelson AS (2002) Modelling viral and immune system dynamics. Nat Rev Immunol 2:28\u201336","journal-title":"Nat Rev Immunol"},{"key":"1583_CR62","doi-asserted-by":"publisher","first-page":"1582","DOI":"10.1126\/science.271.5255.1582","volume":"271","author":"AS Perelson","year":"1996","unstructured":"Perelson AS, Neumann AU, Markowitz M, Leonard JM, Ho DD (1996) HIV-1 dynamics in vivo: virion clearance rate, infected cell life-span, and viral generation time. Science 271:1582\u20131586","journal-title":"Science"},{"key":"1583_CR63","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1007\/s00280-011-1644-6","volume":"69","author":"C P\u00e9rez-Ruixo","year":"2012","unstructured":"P\u00e9rez-Ruixo C, Valenzuela B, Fern\u00e1ndez Teruel C, Gonz\u00e1lez-Sales M, Miguel-Lillo B, Soto-Matos A, P\u00e9rez-Ruixo JJ (2012) Population pharmacokinetics of PM00104 (Zalypsis\u00ae) in cancer patients. Cancer Chemother Pharmacol 69:15\u201324","journal-title":"Cancer Chemother Pharmacol"},{"key":"1583_CR64","doi-asserted-by":"publisher","DOI":"10.1371\/journal.ppat.1012236","volume":"20","author":"T Phan","year":"2024","unstructured":"Phan T, Conway JM, Pagane N, Kreig J, Sambaturu N, Iyaniwura S, Li JZ, Ribeiro RM, Ke R, Perelson AS (2024) Understanding early HIV-1 rebound dynamics following antiretroviral therapy interruption: the importance of effector cell expansion. PLoS Pathog 20:e1012236","journal-title":"PLoS Pathog"},{"key":"1583_CR65","doi-asserted-by":"crossref","unstructured":"Porthiyas J, Nussey D, Beauchemin CAA, Warren DC, Quirouette C, Wilkie KP (2024) Practical parameter identifiability and handling of censored data with Bayesian inference in mathematical tumour models. npj Syst Biol Appl 10:89","DOI":"10.1038\/s41540-024-00409-6"},{"key":"1583_CR66","doi-asserted-by":"crossref","unstructured":"Prague M, Gerold JM, Balelli I, Pasin C, Li JZ, Barouch DH, Whitney JB, Hill AL (2019) Viral rebound kinetics following single and combination immunotherapy for HIV \/ SIV. bioRxiv, pp 1\u201372","DOI":"10.1101\/700401"},{"key":"1583_CR67","doi-asserted-by":"publisher","first-page":"3390","DOI":"10.1007\/s11095-014-1429-9","volume":"31","author":"AL Quartino","year":"2014","unstructured":"Quartino AL, Karlsson MO, Lindman H, Friberg LE (2014) Characterization of endogenous G-CSF and the inverse correlation to chemotherapy-induced neutropenia in patients with breast cancer using population modeling. Pharm Res 31:3390\u20133403","journal-title":"Pharm Res"},{"key":"1583_CR68","doi-asserted-by":"publisher","first-page":"1782","DOI":"10.1016\/S0140-6736(99)02035-8","volume":"354","author":"B Ramratnam","year":"1999","unstructured":"Ramratnam B, Bonhoeffer S, Binley J, Hurley A, Zhang L, Mittler JE, Markowitz M, Moore JP, Perelson AS, Ho DD (1999) Rapid production and clearance of HIV-1 and hepatitis C virus assessed by large volume plasma apheresis. Lancet 354:1782\u20131785","journal-title":"Lancet"},{"key":"1583_CR69","doi-asserted-by":"publisher","first-page":"1440","DOI":"10.1093\/bioinformatics\/btu006","volume":"30","author":"A Raue","year":"2014","unstructured":"Raue A, Karlsson J, Saccomani MP, Jirstrand M, Timmer J (2014) Comparison of approaches for parameter identifiability analysis of biological systems. Bioinformatics 30:1440\u20131448","journal-title":"Bioinformatics"},{"key":"1583_CR70","doi-asserted-by":"publisher","first-page":"1923","DOI":"10.1093\/bioinformatics\/btp358","volume":"25","author":"A Raue","year":"2009","unstructured":"Raue A, Kreutz C, Maiwald T, Bachmann J, Schilling M, Klingm\u00fcller U, Timmer J (2009) Structural and practical identifiability analysis of partially observed dynamical models by exploiting the profile likelihood. Bioinformatics 25:1923\u20131929","journal-title":"Bioinformatics"},{"key":"1583_CR71","doi-asserted-by":"crossref","unstructured":"Reeves DB, Huang Y, Duke ER, Mayer BT, Fabian Cardozo-Ojeda E, Boshier FA, Swan DA, Rolland M, Robb ML, Mascola JR, Cohen MS, Corey L, Gilbert PB, Schiffer JT (2020) Mathematical modeling to reveal breakthrough mechanisms in the HIV antibody mediated prevention (AMP) trials. PLoS Comput Biol 16:1\u201327","DOI":"10.1371\/journal.pcbi.1007626"},{"key":"1583_CR72","doi-asserted-by":"crossref","unstructured":"Reeves DB, Mayer BT, DeCamp AC, Huang Y, Zhang B, Carpp LN, Magaret CA, Juraska M, Gilbert PB, Montefiori DC, Bar KJ, Cardozo-Ojeda EF, Schiffer JT, Rossenkhan R, Edlefsen P, Morris L, Mkhize NN, Williamson C, Mullins JI, Seaton KE, Tomaras GD, Andrew P, Mgodi N, Ledgerwood JE, Cohen MS, Corey L, Naidoo L, Orrell C, Goepfert PA, Casapia M, Sobieszczyk ME, Karuna ST, Edupuganti S (2023) High monoclonal neutralization titers reduced breakthrough HIV-1 viral loads in the antibody mediated prevention trials. Nat Commun 14:8299","DOI":"10.1038\/s41467-023-43384-y"},{"key":"1583_CR73","doi-asserted-by":"publisher","first-page":"1583","DOI":"10.1016\/j.csda.2005.01.014","volume":"50","author":"F Schmid","year":"2006","unstructured":"Schmid F, Schmidt A (2006) Nonparametric estimation of the coefficient of overlapping-theory and empirical application. Comput Stat Data Anal 50:1583\u20131596","journal-title":"Comput Stat Data Anal"},{"key":"1583_CR74","doi-asserted-by":"publisher","first-page":"20210940","DOI":"10.1098\/rsif.2021.0940","volume":"19","author":"JA Sharp","year":"2022","unstructured":"Sharp JA, Browning AP, Burrage K, Simpson MJ (2022) Parameter estimation and uncertainty quantification using information geometry. J R Soc Interface 19:20210940","journal-title":"J R Soc Interface"},{"key":"1583_CR75","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1007\/s11538-021-00982-5","volume":"84","author":"A Sher","year":"2022","unstructured":"Sher A, Niederer SA, Mirams GR, Kirpichnikova A, Allen R, Pathmanathan P, Gavaghan DJ, van der Graaf PH, Noble D (2022) A quantitative systems pharmacology perspective on the importance of parameter identifiability. Bull Math Biol 84:39","journal-title":"Bull Math Biol"},{"key":"1583_CR76","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/psp.2013.25","volume":"2","author":"V Shivva","year":"2013","unstructured":"Shivva V, Korell J, Tucker I, Duffull S (2013) An approach for identifiability of population pharmacokinetic-pharmacodynamic models. CPT Pharmacometrics Syst Pharmacol 2:1\u20139","journal-title":"CPT Pharmacometrics Syst Pharmacol"},{"key":"1583_CR77","unstructured":"Simpson MJ, Baker RE (2024) Parameter identifiability, parameter estimation and model prediction for differential equation models. arXiv:2405.08177, 1\u201327"},{"key":"1583_CR78","unstructured":"Simulations Plus (2023) Monolix"},{"key":"1583_CR79","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1111\/imr.12692","volume":"285","author":"AM Smith","year":"2018","unstructured":"Smith AM (2018) Host-pathogen kinetics during influenza infection and coinfection: insights from predictive modeling. Immunol Rev 285:97\u2013112","journal-title":"Immunol Rev"},{"key":"1583_CR80","doi-asserted-by":"publisher","first-page":"429","DOI":"10.1002\/wsbm.129","volume":"3","author":"AM Smith","year":"2011","unstructured":"Smith AM, Perelson AS (2011) Influenza A virus infection kinetics: quantitative data and models. Wiley Interdiscip Rev Syst Biol Med 3:429\u2013445","journal-title":"Wiley Interdiscip Rev Syst Biol Med"},{"key":"1583_CR81","doi-asserted-by":"publisher","first-page":"375","DOI":"10.1038\/s41586-022-04797-9","volume":"606","author":"MC Sneller","year":"2022","unstructured":"Sneller MC, Blazkova J, Justement JS, Shi V, Kennedy BD, Gittens K, Tolstenko J, McCormack G, Whitehead EJ, Schneck RF, Proschan MA, Benko E, Kovacs C, Oguz C, Seaman MS, Caskey M, Nussenzweig MC, Fauci AS, Moir S, Chun T-W (2022) Combination anti-HIV antibodies provide sustained virological suppression. Nature 606:375\u2013381","journal-title":"Nature"},{"key":"1583_CR82","doi-asserted-by":"publisher","first-page":"553","DOI":"10.1002\/psp4.12548","volume":"9","author":"E Soto","year":"2020","unstructured":"Soto E, Banfield C, Gupta P, Peterson MC (2020) Kinetic-pharmacodynamic model of platelet time course in patients with moderate-to-severe atopic dermatitis treated with oral Janus kinase 1 inhibitor abrocitinib. CPT Pharmacometrics Syst Pharmacol 9:553\u2013560","journal-title":"CPT Pharmacometrics Syst Pharmacol"},{"key":"1583_CR83","doi-asserted-by":"publisher","first-page":"705","DOI":"10.1093\/bioinformatics\/btx676","volume":"34","author":"P Stapor","year":"2018","unstructured":"Stapor P, Weindl D, Ballnus B, Hug S, Loos C, Fiedler A, Krause S, Hro\u00df S, Fr\u00f6hlich F, Hasenauer J (2018) PESTO: parameter estimation toolbox. Bioinformatics 34:705\u2013707","journal-title":"Bioinformatics"},{"key":"1583_CR84","doi-asserted-by":"publisher","first-page":"1718","DOI":"10.1038\/s41591-021-01509-0","volume":"27","author":"KE Stephenson","year":"2021","unstructured":"Stephenson KE, Julg B, Tan CS, Zash R, Walsh SR, Rolle C-P, Monczor AN, Lupo S, Gelderblom HC, Ansel JL, Kanjilal DG, Maxfield LF, Nkolola J, Borducchi EN, Abbink P, Liu J, Peter L, Chandrashekar A, Nityanandam R, Lin Z, Setaro A, Sapiente J, Chen Z, Sunner L, Cassidy T, Bennett C, Sato A, Mayer B, Perelson AS, DeCamp A, Priddy FH, Wagh K, Giorgi EE, Yates NL, Arduino RC, DeJesus E, Tomaras GD, Seaman MS, Korber B, Barouch DH (2021) Safety, pharmacokinetics and antiviral activity of PGT121, a broadly neutralizing monoclonal antibody against HIV-1: a randomized, placebo-controlled, phase 1 clinical trial. Nat Med 27:1718\u20131724","journal-title":"Nat Med"},{"key":"1583_CR85","doi-asserted-by":"publisher","first-page":"198","DOI":"10.1002\/psp4.12500","volume":"9","author":"P Traynard","year":"2020","unstructured":"Traynard P, Ayral G, Twarogowska M, Chauvin J (2020) Efficient pharmacokinetic modeling workflow with the monolixsuite: a case study of remifentanil. CPT Pharmacometrics Syst Pharmacol 9:198\u2013210","journal-title":"CPT Pharmacometrics Syst Pharmacol"},{"key":"1583_CR86","doi-asserted-by":"publisher","first-page":"92","DOI":"10.1097\/COH.0000000000000896","volume":"20","author":"B Vemparala","year":"2024","unstructured":"Vemparala B, Guedj J, Dixit NM (2024) Advances in the mathematical modeling of posttreatment control of HIV-1. Curr Opin HIV AIDS 20:92\u201398","journal-title":"Curr Opin HIV AIDS"},{"key":"1583_CR87","doi-asserted-by":"publisher","first-page":"785","DOI":"10.1007\/s11538-007-9279-9","volume":"70","author":"H Wu","year":"2008","unstructured":"Wu H, Zhu H, Miao H, Perelson AS (2008) Parameter identifiability and estimation of HIV\/AIDS dynamic models. Bull Math Biol 70:785\u2013799","journal-title":"Bull Math Biol"},{"key":"1583_CR88","doi-asserted-by":"publisher","first-page":"1","DOI":"10.7554\/eLife.76284","volume":"11","author":"J Zhang","year":"2022","unstructured":"Zhang J, Cunningham J, Brown J, Gatenby R (2022) Evolution-based mathematical models significantly prolong response to abiraterone in metastatic castrate-resistant prostate cancer and identify strategies to further improve outcomes. Elife 11:1\u2013105","journal-title":"Elife"},{"key":"1583_CR89","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pcbi.1011437","volume":"20","author":"C Zitzmann","year":"2024","unstructured":"Zitzmann C, Ke R, Ribeiro RM, Perelson AS (2024) How robust are estimates of key parameters in standard viral dynamic models? PLoS Comput Biol 20:e1011437","journal-title":"PLoS Comput Biol"}],"container-title":["Bulletin of Mathematical Biology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11538-025-01583-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11538-025-01583-2","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11538-025-01583-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,2,12]],"date-time":"2026-02-12T12:02:46Z","timestamp":1770897766000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11538-025-01583-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1,14]]},"references-count":89,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2026,2]]}},"alternative-id":["1583"],"URL":"https:\/\/doi.org\/10.1007\/s11538-025-01583-2","relation":{},"ISSN":["0092-8240","1522-9602"],"issn-type":[{"value":"0092-8240","type":"print"},{"value":"1522-9602","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,1,14]]},"assertion":[{"value":"27 July 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 December 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 January 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}],"article-number":"19"}}